The global cancer gene therapy market is expected to grow at a CAGR of 16.92% reach US$4.111 billion by 2024 from US$1.454 billion in 2018. The developing rate and pervasiveness of cancer globally are increasing the demand in cancer gene therapy fuelling market development. Research and Innovations in the therapy of cancer are likewise driving the development of the global cancer gene therapy market in the figure time frame.